Key Takeaways
- • Barington Capital Group has accumulated approximately 780,000 Bath & Body Works shares (0.38% stake) and is actively pressing the Columbus, Ohio-based retailer to explore a strategic sale, potentially involving private equity buyers.
- • Activist CEO James Mitarotonda argues that Bath & Body Works is undervalued despite strong brands and cash generation capabilities, citing recent management changes as a drag on performance and contending that "changes are needed" at the company.
- • Barington is seeking board representation and plans to issue a formal letter to directors within weeks, while also calling for financial advisers to be retained to evaluate strategic alternatives and measures including stock buybacks to support share price recovery.
- • Bath & Body Works stock rose approximately 2% in after-hours trading following the activist disclosure but remains down roughly 13% year-to-date amid a difficult retail environment and recent weakness in mall traffic and store visits.
- • The retailer, under CEO Daniel Heaf (appointed last year), has acknowledged that turnaround initiatives remain in early stages and have not yet fully offset operational challenges, with August guidance pointing to larger-than-expected current-quarter sales declines.
Summary
Barington Capital Group has built a notable stake in Bath & Body Works and is mounting an activist campaign to force strategic action at the personal care retailer, according to Bloomberg reporting. The activist investor holds approximately 780,000 shares representing 0.38% ownership as of June 30, and Barington CEO James Mitarotonda has publicly stated that the company is undervalued and should explore a potential sale to private equity or other strategic buyers. Mitarotonda cited the strength of Bath & Body Works' brand portfolio, market position, and cash generation capacity as factors that could appeal to potential acquirers.
Barington's campaign includes specific demands on governance and strategy. The activist intends to seek board representation and plans to deliver a formal letter to the company's directors outlining its position in the coming weeks. Mitarotonda has also called for Bath & Body Works to retain financial advisers to formally evaluate strategic alternatives, and he has advocated for additional shareholder-friendly measures such as stock buybacks to support the depressed share price. The activist contends that "changes are needed" at the retailer, pointing to recent management turnover as a contributing factor to underperformance.
Market reaction to the disclosure was modest but positive, with Bath & Body Works shares gaining approximately 2% in after-hours trading. However, this gain provides limited relief to shareholders, as the stock remains down roughly 13% since the beginning of 2026. The company's operational challenges have mounted in recent months. CEO Daniel Heaf, who assumed leadership last year, has focused on product innovation and digital capability enhancement as part of his turnaround plan. However, in August the company issued guidance signaling a larger-than-expected sales decline in the current quarter, citing weakened store traffic and broader pressure on mall visits. Heaf acknowledged that turnaround initiatives remain in an early phase and have not yet generated sufficient improvements to counterbalance headwinds across the business, suggesting that Barington's concerns about the company's current trajectory carry weight with the investment community.
Barington's campaign includes specific demands on governance and strategy. The activist intends to seek board representation and plans to deliver a formal letter to the company's directors outlining its position in the coming weeks. Mitarotonda has also called for Bath & Body Works to retain financial advisers to formally evaluate strategic alternatives, and he has advocated for additional shareholder-friendly measures such as stock buybacks to support the depressed share price. The activist contends that "changes are needed" at the retailer, pointing to recent management turnover as a contributing factor to underperformance.
Market reaction to the disclosure was modest but positive, with Bath & Body Works shares gaining approximately 2% in after-hours trading. However, this gain provides limited relief to shareholders, as the stock remains down roughly 13% since the beginning of 2026. The company's operational challenges have mounted in recent months. CEO Daniel Heaf, who assumed leadership last year, has focused on product innovation and digital capability enhancement as part of his turnaround plan. However, in August the company issued guidance signaling a larger-than-expected sales decline in the current quarter, citing weakened store traffic and broader pressure on mall visits. Heaf acknowledged that turnaround initiatives remain in an early phase and have not yet generated sufficient improvements to counterbalance headwinds across the business, suggesting that Barington's concerns about the company's current trajectory carry weight with the investment community.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.